Sling Therapeutics Appoints Ken Lock As Chief Commercial Officer

Jun 18, 2025•2 months ago

Position

Chief Commercial Officer

Company

Sling Therapeutics

Ken Lock

Ann ArborBiotechnologyHealth Care

Description

Sling Therapeutics, Inc. announces the appointment of Ken Lock as Chief Commercial Officer. He brings over 20 years of commercial leadership experience as the company prepares for its confirmatory Phase 3 study of linsitinib for thyroid eye disease.

Company Information

Company

Sling Therapeutics

Location

Ann Arbor, Michigan, United States

About

Sling Therapeutics is a clinical-stage biopharmaceutical company focused on developing an oral small molecule therapy for the treatment of thyroid eye disease (TED). Our team is composed of seasoned drug development professionals, supported by a global network of experts through our Scientific Advisory Board.

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months